Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023

BUY
$122.0 - $145.31 $208,620 - $248,480
1,710 New
1,710 $221,000
Q1 2023

May 15, 2023

BUY
$133.98 - $160.47 $937 - $1,123
7 Added 0.45%
1,570 $229,000
Q4 2022

Feb 13, 2023

SELL
$129.72 - $159.85 $518 - $639
-4 Reduced 0.26%
1,563 $249,000
Q3 2022

Nov 14, 2022

BUY
$126.59 - $161.18 $3,038 - $3,868
24 Added 1.56%
1,567 $209,000
Q2 2022

Aug 16, 2022

SELL
$141.59 - $168.66 $12,176 - $14,504
-86 Reduced 5.28%
1,543 $241,000
Q1 2022

Feb 08, 2024

BUY
$129.64 - $160.7 $203,664 - $252,459
1,571 New
1,571 $244,000
Q4 2021

Feb 17, 2022

BUY
$119.87 - $145.67 $7,192 - $8,740
60 Added 3.82%
1,629 $208,000
Q3 2021

Dec 03, 2021

BUY
$128.64 - $184.79 $201,836 - $289,935
1,569 New
1,569 $204,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Kingsview Wealth Management, LLC Portfolio

Follow Kingsview Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kingsview Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kingsview Wealth Management, LLC with notifications on news.